Article
KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Feb 2015
Joensuu Heikki, Rutkowski Piotr, Nishida Toshirou, Steigen Sonja E, Brabec Peter, Plank Lukas, Nilsson Bengt, Braconi Chiara, Bordoni Andrea, Magnusson Magnus K, Sufliarsky Jozef, Federico Massimo, Jonasson Jon G, Hostein Isabelle, Bringuier Pierre-Paul, Emile Jean-Francois
Abstract excerpt
PURPOSE: Mutated KIT and platelet-derived growth factor alpha gene (PDGFRA) drive GI stromal tumor (GIST) oncogenesis, but the clinical significance of their single mutations is known incompletely. PATIENTS AND METHODS: We identified 11 population-based series of patients with GIST through a literature search and pooled individual data from 3,067 patients treated with macroscopically complete tumor excision....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
